Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 2,100 | 1,372 | 1,856 | 3,067 | 3,051 |
| Cost of Goods | 1,774 | 775 | 1,418 | 908 | 1,016 |
| Gross Profit | 326 | 597 | 438 | 2,159 | 2,035 |
| Operating Expenses | 27,072 | 32,286 | 47,671 | 29,138 | 31,096 |
| Operating Income | -25,972 | -30,914 | -46,815 | -26,071 | -29,045 |
| Interest Expense | 2,207 | 2,035 | 2,076 | 2,072 | 2,091 |
| Other Income | 68 | 8 | 1,323 | 16 | -5,362 |
| Pre-tax Income | -28,111 | -32,941 | -47,568 | -28,127 | -36,498 |
| Net Income Continuous | -28,111 | -32,941 | -47,568 | -28,127 | -36,498 |
| Net Income | $-28,111 | $-32,941 | $-47,568 | $-28,127 | $-36,498 |
| EPS Basic Total Ops | -946.00 | -1,109.00 | -1,695.50 | -1,070.50 | -1,425.00 |
| EPS Basic Continuous Ops | -945.86 | -1,109.13 | -1,700.43 | -1,071.10 | -1,413.47 |
| EPS Diluted Total Ops | -946.00 | -1,109.00 | -1,695.50 | -1,070.50 | -1,425.00 |
| EPS Diluted Continuous Ops | -945.86 | -1,109.13 | -1,700.43 | -1,071.10 | -1,413.47 |
| EBITDA(a) | $-25,384 | $-30,325 | $-46,164 | $-25,377 | $-28,422 |